Nearwater Capital Markets »

Nektar Therapeutics shares owned by Nearwater Capital Markets

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Nearwater Capital Markets from 13F filings

Historical chart of Nearwater Capital Markets investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Nearwater Capital Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Nearwater Capital Markets

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.6M 62k 42.28

More positions owned by Nearwater Capital Markets

Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Apple (AAPL)
Micron Technology (MU)
Vaneck Etf Trust Junior Gold Mine (GDXJ)
Wal-Mart Stores (WMT)
Lam Research Corp Com New (LRCX)
Tesla Motors (TSLA)
Marvell Technology (MRVL)
Gilead Sciences (GILD)
Southwest Airlines (LUV)

View all positions for Nearwater Capital Markets

Top funds holding Nektar Therapeutics

BVF
Susquehanna International
Vanguard Group
Citadel Advisors
Two Seas Capital
BlackRock
Millennium Management
Prosight Management
Invesco
Point72 Asset Management
Sofinnova Ventures
Two Sigma Investments
Emerald Advisers
22NW
Qube Research & Technologies

View all funds holding Nektar Therapeutics